Key result
Cardiac pacemakers linked to ~16% rate of significant depressive symptoms versus healthy controls.
Why the study?
Knowledge regarding the pattern and prevalence of clinically significant psychiatric symptomatology among patients with cardiac pacemakers, especially posttraumatic stress symptoms, is limited.
Are symptoms of depression, anxiety, and posttraumatic stress more prevalent in patients with cardiac pacemakers compared to other chronic disease patients or healthy controls?
Cross-Sectional (n=120)
No
Are symptoms of depression, anxiety, and posttraumatic stress more prevalent in patients with cardiac pacemakers compared to other chronic disease patients or healthy controls?
Absolute Event Rate: 16.2% vs 0%
p-value: p=<0.001
Patients with cardiac pacemakers experience a significantly higher prevalence of clinically relevant depressive symptoms compared to healthy controls, highlighting the need for routine psychiatric screening in this population.
Higher depressive symptoms in pacemaker patients vs controls; hypothesis-generating and requires prospective confirmation before screening changes.
Despite being a prerequisite for tailoring specific therapeutic interventions, knowledge of pattern and prevalence of clinically significant psychiatric symptomatology among patients with cardiac pacemakers (PMs), especially of symptoms of posttraumatic stress, is limited. We studied symptoms of depression, anxiety, and posttraumatic stress among PM patients (PM due to syncope or presyncope) compared to participants of (i) a cardiac, (ii) a chronic disease, and (iii) a healthy control group. Symptoms of depression, anxiety and posttraumatic stress were measured by validated self-report scales at least 6 months after implantation of the PM (PM group; n = 38), percutaneous coronary intervention (PCI; PCI control group; n = 23), and first dialysis (Dialysis control group; n = 17). Blood donors constituted the Healthy control group (n = 42). Both PM, PCI, and dialysis patients reported depressive symptoms above clinical cut-off more frequently than the healthy controls (16.2, 26.1, 41.2, and 0%, respectively; p < 0.001). Self-report of symptoms of anxiety and posttraumatic stress did not differ significantly across study groups. However, a non-negligible proportion of PM patients reported on symptoms of posttraumatic stress of anticipated clinical relevance. Identification and treatment of depression deserves attention in clinical routine in all three patient populations. Further study of posttraumatic stress in PM patients seems advisable.
No takes yet. Share an insight, caveat, or question.
Bürker et al. (2022) conducted a cross-sectional in Cardiac pacemakers (n=120). Cardiac pacemaker implantation vs. Healthy controls, PCI patients, and dialysis patients was evaluated on Clinically significant depressive symptoms (PHQ-9 total score ≥ 10) (p=<0.001). Patients with cardiac pacemakers reported clinically significant depressive symptoms more frequently than healthy controls (16.2% vs 0%, p<0.001), though anxiety and posttraumatic stress symptoms did not differ significantly.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: